Hyo Jung Park

Dr. Hyo Jung Park


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2018 in International Journal of Clinical Pharmacy
Verified
Journal Article
Closed access
PDF file
SPSo Jin Park
So Jin Park
NLNa Ri Lim
Na Ri Lim
HPHyo Jung Park
Hyo Jung Park
JYJae Wook Yang
Jae Wook Yang
MKMin-Ji Kim
Min-Ji Kim
YLYoung Mee Lee
Young Mee Lee

1 January 2022 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
DKDongsub Kim
Dongsub Kim
HLHaejeong Lee
Haejeong Lee
JCJoon-Sik Choi
Joon-Sik Choi
CCChristina M. Croney
Christina M. Croney
KPKi-Sup Park
Ki-Sup Park
YKYae-Jean Kim
Yae-Jean Kim
Kim D, et al. J Korean Med Sci. 2022 Jun;37(24):e196. https://doi.org/10.3346/jkms.2022.37.e196

17 March 2020 in Journal of Parenteral and Enteral Nutrition
Verified
Journal Article
Closed access
PDF file
HPHyo Jung Park
Hyo Jung Park
SLSanghoon Lee
Sanghoon Lee
CPChi‐Min Park
Chi‐Min Park
KYKeesang Yoo
Keesang Yoo
JSJeong‐Meen Seo
Jeong‐Meen Seo

10 August 2022 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
ENEliel Nham
Eliel Nham
KHKyungmin Huh
Kyungmin Huh
YSYou Min Sohn
You Min Sohn
HPHyo Jung Park
Hyo Jung Park
HKHyemee Kim
Hyemee Kim
KPKyong Ran Peck
Kyong Ran Peck
Purpose: To find pharmacokinetic/pharmacodynamic parameters of vancomycin associated with the optimal outcome of severe infection due to Enterococcus species. Methods: We retrospectively reviewed enterococcal bacteremia cases treated with vancomycin from January 2015 to December 2020. The primary outcome was 30-day mortality. We calculated cutoff values of the ratio of vancomycin area under the concentration–time curve over 24 h to the minimum inhibitory concentration (AUC24/MIC) and trough concentration (Ctrough) during the initial 72 h of treatment. The optimal cutoff value was determined using the Youden index. Binary variables created based on these cutoffs were further assessed using multivariable analysis. Results: A total of 65 patients were included. The majority (87.7%) had solid or hematologic malignancies. Thirty-day mortality and nephrotoxicity occurred in nine (13.4%) and 14 (21.5%) patients, respectively. Both vancomycin AUC24/MIC and Ctrough showed fair performance in predicting 30-day mortality (AUC of receiver-operator curve for AUC24/MIC, 0.712; 95% confidence interval [CI] 0.539–0.886; AUC for Ctrough, 0.760; 95% CI 0.627–0.892; pairwise AUC comparison: p = 0.570). Ctrough ≥ 13.94 μg/mL, but not AUC24/MIC ≥ 504, had a significant association with 30-day mortality after adjusting for confounders (odds ratio, 8.40; 95% CI 1.60–86.62; p = 0.010). Conclusion: Mean Ctrough ≥ 13.94 μg/mL during the initial 72 h was associated with higher 30-day mortality in enterococcal bacteremia. Further studies are warranted to elucidate optimal pharmacokinetic targets for enterococcal bacteremia.

23 October 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SLSanghoon Lee
Sanghoon Lee
SSSe In Sung
Se In Sung
HPHyo Jung Park
Hyo Jung Park
YCYun Sil Chang
Yun Sil Chang
WPWon Soon Park
Won Soon Park
JSJeong-Meen Seo
Jeong-Meen Seo
Intestinal failure-associated liver disease (IFALD) is a life-threatening complication of parenteral nutrition (PN) and is most prevalent in the preterm neonatal population receiving long-term PN. In this study, we report the outcome of our experience with fish oil monotherapy for IFALD in a fish oil-based combination lipid emulsion administered to preterm low birth weight infants. Fasting neonates were administered as PN according to our center’s nutrition protocol. A diagnosis of IFALD was made when the serum direct bilirubin levels were >2.0 mg/dL in two consecutive measurements that were more than one week apart, without evidence of intrinsic causes of liver dysfunction. The management of IFALD was conducted by switching the lipid emulsion from combination lipid emulsion to fish oil monotherapy at 1.0 g/kg/day, infused over 24 h. Fifteen infants met the criteria for IFALD and received fish oil monotherapy. The median gestational age was 27.5 weeks and the median birth weight was 862.5 g. IFALD was successfully reversed in 11 infants (11/15, 73.3%). The median duration of fish oil monotherapy was 39 days. Direct bilirubin values were initially elevated and then steadily declined from the third week of treatment onward. The enteral tolerance increased in varying degrees during the treatment period. The mean weight gain was 26.0 g/day during fish oil monotherapy. Omegaven® (Fresenius Kabi Austria Gmbh, Graz, Austria) at a dose of 1.0 g/kg/day was well tolerated, and no adverse events related to Omegaven use were seen. The reversal of IFALD in preterm infants on combination lipid emulsion containing fish oil was achieved by switching to fish oil monotherapy.

29 May 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
SCSeunghyun Cheon
Seunghyun Cheon
SOSang-Hyeon Oh
Sang-Hyeon Oh
JKJung-Tae Kim
Jung-Tae Kim
HCHan-Gon Choi
Han-Gon Choi
HPHyo Jung Park
Hyo Jung Park
JCJee Eun Chung
Jee Eun Chung
This study aimed to investigate the activity of a nutrition support team (NST) and the trends of multi-chamber bag (MCB) and customized parenteral nutrition (PN) with NST consultations in South Korea. Data were obtained from the National Inpatient Sample Cohort between 2015 and 2020. Three datasets were constructed for NST consultation, MCB-PN product prescriptions, and aseptic preparation of total PN. The intersections of the NST consultation and each PN dataset were compiled into MCB-PN with NST or customized PN with a NST sub-dataset, respectively. Using personal identifiers, the patients’ characteristics were evaluated in the NST cohort. A total of 91,384 reimbursements and 70,665 patients were included. The NST activity had increased by more than 50% over 6 years. Approximately 70% and 11%, respectively, of the NST cohort were classified into two subgroups: MCB-PN with NST (M-NST) and customized PN with NST (C-NST). M-NST had many elderly patients with cancer and showed a higher in-hospital mortality than C-NST (12.6% vs. 9.5%). C-NST included a larger number of patients under the age of 5 years, and the hospitalization period was more extended than M-NST (26.2 vs. 21.2 days). The present study showed that NST activities and the proportion of PN with NST consultation are gradually increasing in South Korea.